Viewing data from:

NALMEFENE HYDROCHLORIDE

ANDA

NALMEFENE HYDROCHLORIDE | A216007 | CHENGDU SHUODE PHARMACEUTICAL CO LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SPECGX LLCNALMEFENE HYDROCHLORIDE

DMF 156632001

RUSAN PHARMA LTDNALMEFENE HYDROCHLORIDE

DMF 343672019

SICHUAN QINGMU PHARMACEUTICAL CO LTDNALMEFENE HYDROCHLORIDE

DMF 367512022

PURISYS LLCNALMEFENE HYDROCHLORIDE DRUG SUBSTANCE

DMF 397672024

SANOFI SAInactiveNALMEFENE HYDROCHLORIDE

DMF 54841984

NV ORGANONInactiveNALMEFENE HYDROCHLORIDE

DMF 56421984

TASMANIAN ALKALOIDS PROPRIETARY LTDInactiveNALMEFENE HYDROCHLORIDE

DMF 85071990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | Approved: Nov 15, 2023

No patent or exclusivity listings for this strength.

#002 — EQ 2MG BASE/2ML (EQ 1MG BASE/ML)

0 patents0 exclusivities▾

SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | Approved: Nov 15, 2023